A Chinese firm seeks permission to market a vaccine before announcing it has completed trials.
Reviewed by Oppozit
on
November 24, 2020
Rating:
By Roger Cohen and Aurelien Breeden from NYT World https://ift.tt/yinKbf7 via IFTTT
No comments: